Wells Fargo’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-342
| Closed | – | – | 7622 |
|
|
2022
Q2 | $0 | Buy |
342
+59
| +21% | – | ﹤0.01% | 7658 |
|
|
2022
Q1 | $1K | Sell |
283
-1
| -0.4% | -$4 | ﹤0.01% | 6585 |
|
|
2021
Q4 | $1K | Buy |
284
+3
| +1% | +$11 | ﹤0.01% | 6578 |
|
|
2021
Q3 | $3K | Sell |
281
-2
| -0.7% | -$21 | ﹤0.01% | 6206 |
|
|
2021
Q2 | $4K | Sell |
283
-1,451
| -84% | -$20.5K | ﹤0.01% | 6094 |
|
|
2021
Q1 | $45K | Sell |
1,734
-1,897
| -52% | -$49.2K | ﹤0.01% | 5512 |
|
|
2020
Q4 | $132K | Buy |
3,631
+1,248
| +52% | +$45.4K | ﹤0.01% | 5100 |
|
|
2020
Q3 | $85K | Sell |
2,383
-402
| -14% | -$14.3K | ﹤0.01% | 5119 |
|
|
2020
Q2 | $118K | Buy |
2,785
+1,359
| +95% | +$57.6K | ﹤0.01% | 4947 |
|
|
2020
Q1 | $114K | Sell |
1,426
-43
| -3% | -$3.44K | ﹤0.01% | 4806 |
|
|
2019
Q4 | $136K | Buy |
1,469
+1
| +0.1% | +$93 | ﹤0.01% | 4980 |
|
|
2019
Q3 | $111K | Buy |
1,468
+1,461
| +20,871% | +$110K | ﹤0.01% | 5044 |
|
|
2019
Q2 | $1K | Buy |
+7
| New | +$1K | ﹤0.01% | 5832 |
|
|
2016
Q2 | – | Sell |
-9
| Closed | – | – | 6054 |
|
|
2016
Q1 | $0 | Sell |
9
-13
| -59% | – | ﹤0.01% | 6150 |
|
|
2015
Q4 | $3K | Hold |
22
| – | – | ﹤0.01% | 5683 |
|
|
2015
Q3 | $16K | Buy |
22
+20
| +1,000% | +$14.5K | ﹤0.01% | 5357 |
|
|
2015
Q2 | $2K | Buy |
+2
| New | +$2K | ﹤0.01% | 5884 |
|